Market Research Report
MicroRNAs and Exosomes Market Report 2012
|Published by||Select Biosciences||Product code||248301|
|Published||Content info||168 Pages
Delivery time: 1-2 business days
|MicroRNAs and Exosomes Market Report 2012|
|Published: August 9, 2012||Content info: 168 Pages||
Disease Associations and Circulating Biomarkers
This is the latest and most up-to-date Market Report from Select Biosciences addressing the microRNA and Exosomes markets as they are evolving. In this report, we focus upon the microRNA research marketplace from the perspective of the translational opportunities in these spaces. The focus of this field is moving from basic research towards the utility of associations of microRNA expression patterns in disease. In this manner, microRNA signatures may be validated as biomarkers in many disease areas - cancers, cardiovascular disease, neurological disease, inflammation, and metabolic diseases.
Select Biosciences has characterized the associations of microRNAs in various disease classes and presents these detailed associations as "hotspot maps" in this report. Specifically, these associations [to be interpreted as starting material for biomarker development and validation] are described for many cancer classes, cardiovascular disease, CNS disease, diabetes, inflammation, and obesity. They offer the opportunity for R&D planning efforts addressing the question of "which microRNA content needs to be addressed in a particular disease class."
This data-driven characterization of the microRNAs and Exosomes landscape is a hands-on document that can be used for competitive benchmarking, business planning, and strategy development - all the data that have been collected in this industry analysis are presented and they form the basis for the conclusions drawn throughout the market report presented in a format enabling "drag-and-drop" into business presentations/business plans - this Market Report is written and delivered to customers in PowerPoint format.